Stay updated with breaking news from Groupa Strep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Company Expects to Initiate VAX-31 Phase 1/2 Study in Healthy Adults This Quarter-- -- Topline Safety, Tolerability and Immunogenicity Results from VAX-31 Phase 1/2 Study Expected in the Second...
-- New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte's PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Pop...
British scientists have started a pioneering trial to find a vaccine for Group A Strep, which can lead to deadly diseases including meningitis, using a new technique
Scarlet fever is known for causing a rash, but as cases of the bacterial illness spike in Britain people are being advised that this is not in fact the first sign to keep an eye out for
SAN CARLOS, Calif., Sept. 19, 2023 -- Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial...